U.S. federal trademark · Serial No. 98044266
Design and testing for new cell product development, namely, natural killer cell, gamma delta T cell, stem cell, or other cell product development; Platform as a service (PAAS) to develop cell products to improve ability to target tumor cells or other abnormal cells; Platform as a service (PAAS) for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease; Providing information of cells and cell-derived preparations; Providing products for use in the fields of cell therapy and regenerative medicine services
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.